Patients with diabetes are an extremely heterogeneous group in terms of glycemic control, coexistence of diabetes complications, medication used, diet, degree of obesity, and endogenous insulin levels.Systemically followed-up patients in the same center are of course individually treated but, more or less, treated according to the same therapeutic perception. The gene discussed is INS; the disease is diabetes mellitus.